249 related articles for article (PubMed ID: 25840984)
1. Leptin-STAT3-G9a Signaling Promotes Obesity-Mediated Breast Cancer Progression.
Chang CC; Wu MJ; Yang JY; Camarillo IG; Chang CJ
Cancer Res; 2015 Jun; 75(11):2375-2386. PubMed ID: 25840984
[TBL] [Abstract][Full Text] [Related]
2. STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers.
Chang YF; Lim KH; Chiang YW; Sie ZL; Chang J; Ho AS; Cheng CC
BMC Cancer; 2019 Oct; 19(1):959. PubMed ID: 31619200
[TBL] [Abstract][Full Text] [Related]
3. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.
Wei L; Chiu DK; Tsang FH; Law CT; Cheng CL; Au SL; Lee JM; Wong CC; Ng IO; Wong CM
J Hepatol; 2017 Oct; 67(4):758-769. PubMed ID: 28532996
[TBL] [Abstract][Full Text] [Related]
4. G9a regulates breast cancer growth by modulating iron homeostasis through the repression of ferroxidase hephaestin.
Wang YF; Zhang J; Su Y; Shen YY; Jiang DX; Hou YY; Geng MY; Ding J; Chen Y
Nat Commun; 2017 Aug; 8(1):274. PubMed ID: 28819251
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine kinase 1 contributes to leptin-induced STAT3 phosphorylation through IL-6/gp130 transactivation in oestrogen receptor-negative breast cancer.
Alshaker H; Wang Q; Frampton AE; Krell J; Waxman J; Winkler M; Stebbing J; Cooper C; Yagüe E; Pchejetski D
Breast Cancer Res Treat; 2015 Jan; 149(1):59-67. PubMed ID: 25481644
[TBL] [Abstract][Full Text] [Related]
6. G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis.
Casciello F; Al-Ejeh F; Kelly G; Brennan DJ; Ngiow SF; Young A; Stoll T; Windloch K; Hill MM; Smyth MJ; Gannon F; Lee JS
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):7077-7082. PubMed ID: 28630300
[TBL] [Abstract][Full Text] [Related]
7. Novel Function of Lysine Methyltransferase G9a in the Regulation of Sox2 Protein Stability.
Lee JY; Lee SH; Heo SH; Kim KS; Kim C; Kim DK; Ko JJ; Park KS
PLoS One; 2015; 10(10):e0141118. PubMed ID: 26492085
[TBL] [Abstract][Full Text] [Related]
8. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway.
Yang J; Liao D; Chen C; Liu Y; Chuang TH; Xiang R; Markowitz D; Reisfeld RA; Luo Y
Stem Cells; 2013 Feb; 31(2):248-58. PubMed ID: 23169551
[TBL] [Abstract][Full Text] [Related]
10. Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.
Giordano C; Chemi F; Panza S; Barone I; Bonofiglio D; Lanzino M; Cordella A; Campana A; Hashim A; Rizza P; Leggio A; Győrffy B; Simões BM; Clarke RB; Weisz A; Catalano S; Andò S
Oncotarget; 2016 Jan; 7(2):1262-75. PubMed ID: 26556856
[TBL] [Abstract][Full Text] [Related]
11. STAT3 activation by leptin receptor is essential for TNBC stem cell maintenance.
Thiagarajan PS; Zheng Q; Bhagrath M; Mulkearns-Hubert EE; Myers MG; Lathia JD; Reizes O
Endocr Relat Cancer; 2017 Aug; 24(8):415-426. PubMed ID: 28729467
[TBL] [Abstract][Full Text] [Related]
12. G9a-mediated methylation of ERα links the PHF20/MOF histone acetyltransferase complex to hormonal gene expression.
Zhang X; Peng D; Xi Y; Yuan C; Sagum CA; Klein BJ; Tanaka K; Wen H; Kutateladze TG; Li W; Bedford MT; Shi X
Nat Commun; 2016 Mar; 7():10810. PubMed ID: 26960573
[TBL] [Abstract][Full Text] [Related]
13. Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival.
Zheng Q; Dunlap SM; Zhu J; Downs-Kelly E; Rich J; Hursting SD; Berger NA; Reizes O
Endocr Relat Cancer; 2011 Aug; 18(4):491-503. PubMed ID: 21636700
[TBL] [Abstract][Full Text] [Related]
14. Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner.
Avtanski DB; Nagalingam A; Kuppusamy P; Bonner MY; Arbiser JL; Saxena NK; Sharma D
Oncotarget; 2015 Jun; 6(18):16396-410. PubMed ID: 26036628
[TBL] [Abstract][Full Text] [Related]
15. G9a-mediated repression of CDH10 in hypoxia enhances breast tumour cell motility and associates with poor survival outcome.
Casciello F; Al-Ejeh F; Miranda M; Kelly G; Baxter E; Windloch K; Gannon F; Lee JS
Theranostics; 2020; 10(10):4515-4529. PubMed ID: 32292512
[No Abstract] [Full Text] [Related]
16. G9a Knockdown Suppresses Cancer Aggressiveness by Facilitating Smad Protein Phosphorylation through Increasing BMP5 Expression in Luminal A Type Breast Cancer.
Jin Y; Park S; Park SY; Lee CY; Eum DY; Shim JW; Choi SH; Choi YJ; Park SJ; Heo K
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054776
[TBL] [Abstract][Full Text] [Related]
17. The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer.
Hsiao SM; Chen MW; Chen CA; Chien MH; Hua KT; Hsiao M; Kuo ML; Wei LH
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1556-65. PubMed ID: 25613390
[TBL] [Abstract][Full Text] [Related]
18. Histone methyltransferase G9a modulates hepatic insulin signaling via regulating HMGA1.
Xue W; Huang J; Chen H; Zhang Y; Zhu X; Li J; Zhang W; Yuan Y; Wang Y; Zheng L; Huang K
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):338-346. PubMed ID: 29101051
[TBL] [Abstract][Full Text] [Related]
19. G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma.
Liu S; Ye D; Guo W; Yu W; He Y; Hu J; Wang Y; Zhang L; Liao Y; Song H; Zhong S; Xu D; Yin H; Sun B; Wang X; Liu J; Wu Y; Zhou BP; Zhang Z; Deng J
Oncotarget; 2015 Mar; 6(9):6887-901. PubMed ID: 25749385
[TBL] [Abstract][Full Text] [Related]
20. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM.
Chen MW; Hua KT; Kao HJ; Chi CC; Wei LH; Johansson G; Shiah SG; Chen PS; Jeng YM; Cheng TY; Lai TC; Chang JS; Jan YH; Chien MH; Yang CJ; Huang MS; Hsiao M; Kuo ML
Cancer Res; 2010 Oct; 70(20):7830-40. PubMed ID: 20940408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]